Neuchâtel, Switzerland

Luca Rossi

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luca Rossi. Retrieved from https://idiyas.com/inventor/luca-rossi-54480lnt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Luca Rossi in Animal Cell Transformation

Introduction

Luca Rossi is an accomplished inventor based in Neuchâtel, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the transformation of animal cells. His innovative methods have the potential to advance research and applications in various biological fields.

Latest Patents

Luca Rossi holds a patent for a "Method for transformation of animal cells." This invention relates to a method for introducing nucleic acids into cells, which can be used for producing transiently transfected or stably transformed animal cells. The method utilizes a specifically designed nucleic acid/protein complex that includes a VirD2 protein, preferably in conjunction with a VirE2 protein. This innovative approach enhances the efficiency of cell transformation processes.

Career Highlights

Luca Rossi is currently employed at Novartis AG, a leading global healthcare company. His work at Novartis has allowed him to collaborate with other experts in the field and contribute to groundbreaking research in biotechnology. His dedication to innovation is evident in his patent and ongoing research efforts.

Collaborations

Luca has worked alongside notable colleagues such as Biserka Relic and Barbara Hohn. These collaborations have fostered a productive environment for scientific discovery and innovation.

Conclusion

Luca Rossi's contributions to the field of animal cell transformation exemplify the impact of innovative thinking in biotechnology. His patent and work at Novartis AG highlight his commitment to advancing scientific knowledge and applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…